BeCRO co-organizer of a luncheon event, at BIO 2016 in San Francisco, introduced by Minister Maggie De Block

 

Bio San Francisco on June 7, 2016 :

BeCRO co-organized with Bruxelles Invest & Export a luncheon event, introduced by Belgian Federal Minister of Public Health and Social Affairs, Maggie De Block, to reinforce Belgium’s commitment to patients health and consequently its support to clinical research in Belgium (follow this link to Minister De Block’s speech).

The next distinguished speakers and panelists were:

• Mrs Patricia Massetti, AVP & Managing Director, MSD Belgium and Luxemburg.
• Mr Yves Zinggeler, General Manager, Amgen Belgium and Luxemburg.
• Dr Dirk Vander Mijnsbrugge, Senior Medical Affairs Director, Western Europe, Pfizer Innovative Business Unit.
• Mr Bruno Speder, Head Clinical Regulatory Affairs, SGS Clinical Research.

Approximately 40 biotech companies attended this event. One company decided to perform its first phase I clinical trial in Belgium.

Minister DE BLOCK Speech Clinical trials June 7_2016